According to GlobalData’s medical device pipeline database, 47 Critical Care Ventilators devices are in various stages of development globally. GlobalData’s report Critical Care Ventilators provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.

Smarter leaders trust GlobalData


Premium Insights Innovations in Nebulizers - Global Pipeline Summary

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

Of these devices, 29 are in active development, while the remaining 18 are in an inactive stage of development. There are 17 products in the early stages of development, and the remaining 12 are in the late stages of development.

Critical care ventilators also known as intensive care ventilators, provide artificial respiratory support to critical patients in ICUs. These devices are controlled by a microprocessor integrated facility and suitable for neonatal, pediatric and adult patients. The device is equipped with set of valves and tubes, a compressible air reservoir, continuous supply of – air, oxygen and power supply and a disposable/reusable circuit. One unit refers to one critical care ventilator. The critical care ventilators, covers devices that can only be operated in an “unattended” mode of action, the devices with alarms and alerting functions. This does not include devices that are intended for short-term and non-continuous use, such as some portable ventilators.

Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.

Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Critical Care Ventilators pipeline devices are all expected to be approved within the next ten years.

Currently, private organizations, public entities and institutions are working on the development of Critical Care Ventilators devices. Overall, most of these Critical Care Ventilators pipeline devices are being developed by private entities.

Key players involved in the active development of Critical Care Ventilators include AgVa Healthcare, Mahindra & Mahindra, University of Arizona, University of California Los Angeles, University of Connecticut, University of Florida, Wise Ally International, X-Biomedical, Massachusetts Institute of Technology and Naval Sea Logistics Center.

For a complete picture of the developmental pipeline for Critical Care Ventilators devices, buy the report here.

Premium Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. The Pipeline Products database is a is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.